The final issue in our health series brings in a global perspective. Four of our authors take a look at the EU approach to pharm.; in particular, at the Italian…

Svetlana Avdasheva, Andrey Shastitko, Jul 27, 2012 The Law ‘On Trade,’ adopted in the Russian Federation at the end of 2009, introduced a set of rules that regulate the terms…

Patrick Harrison, Kristina Nordlander, Jul 27, 2012 In June 2005, the European Commission issued a decision finding that AstraZeneca had breached Article 102 TFEUby engaging in conduct aimed at blocking…

Stefano Grassani, Jul 27, 2012 On Jan. 11, 2012, the Italian Antitrust Authority (“IAA”) found Pfizer Inc. and its Swedish and Italian subsidiaries guilty of abuse of dominant position pursuant…

Daniela Ampollini, Jul 27, 2012 The January 2012 decision of the Italian Antitrust Authority (“IAA”) in the Pfizer case, involving Pfizer’s actions to counter the marketing of generic versions of its…

Sean-Paul Brankin, Jul 27, 2012 On July 6, 2011, the European Commission closed the case file in itsBoehringer/Almirall investigation. It did so without a formal decision, without formal remedies, and…

John Bigelow, Jul 27, 2012 In the June issue of this Chronicle my fellow contributors and I described a trend in appellate court decisions involving so called “Reverse Payment” settlements.…

Rosa Abrantes-Metz, Jul 27, 2012 There is nearly universal agreement that a restructuring of the health care system is required, particularly with regard to the public financing of health care.…

Kai Zhang, Jul 27, 2012 Monopoly refers to the phenomenon whereby a specific person or enterprise accrues substantial profits by controlling the production and selling of a particular commodity. International…